The Evolut FX system [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + released positive results from a two-year trial of Evolut TAVR that demonstrated superior valve performance in patients ...

"The two-year results highlight the continued superior performance of the Evolut TAVR valve in these patients. While we would not yet expect to see a significant difference in the composite ...

and continued superior valve performance as measured by bioprosthetic valve dysfunction (BVD) at two years for Evolut™ TAVR compared to SAPIEN™. The late-breaking science was presented at the ...

Opportunities are being explored to 'maximise' the use of St Mark's Hospital site in Maidenhead, an NHS boss told a meeting this week. At a disability and inclusion forum meeting on Monday ...

Opportunities are being explored to 'maximise' the use of St Mark's Hospital site in Maidenhead, an NHS boss told a meeting this week. At a disability and inclusion forum meeting on Monday, members ...

The two-year results highlighted the continued superior performance of the Evolut TAVR valve in patients with ... soon after the company received CE mark approval in the European Union (EU ...

St. Mary’s Hospital will add an 8-story tower to its campus, which will be the largest capital project in the hospital’s history. The Henrico County facility, owned by Bon Secours, will break ...

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

Ahead of print articles are peer reviewed, accepted articles to be published in this publication. When the final article is assigned to volumes/issues of the publication, the ahead of print article ...